INTERNATIONAL PATENT: RETEX PHARMACEUTICALS, INC. FILES APPLICATION FOR "VASOPRESSIN RECEPTOR 2 MODULATORS AND METHODS OF USE THEREOF"

GENEVA, Feb. 18 -- RETEX PHARMACEUTICALS, INC. (134 Coolidge AvenueWatertown, Massachusetts 02472) filed a patent application (PCT/US2025/040781) for "VASOPRESSIN RECEPTOR 2 MODULATORS AND METHODS OF USE THEREOF" on Aug 05, 2025. With publication no. WO/2026/035773, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SU, Zhenwei (c/o Retex Pharmaceuticals, Inc.134 Coolidge AvenueWatertown, Massachusetts 02472), ZHU, Wei (c/o Retex Pharmaceuticals, Inc.134 Coolidge AvenueWatertown, Massachusetts 02472), ZHAO, Shuhai (c/o Retex...